Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma

W K Hofmann1, K Tsukasaki, N Takeuchi

  • 1Division of Hematology/Oncology, Cedars-Sinai Research Institute, UCLA School of Medicine, Los Angeles, California 90048, USA.

Leukemia & Lymphoma
|November 8, 2001
PubMed

Insights

Hypermethylation of cell cycle genes, including p15INK4b, p14ARF, and p16INK4a, is prevalent in adult T-cell leukemia/lymphoma (ATL). This gene inactivation is crucial for ATL development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Aberrant gene expression driving the cell cycle is central to cancer development.
  • Key regulators include cyclin-dependent kinase inhibitors (p15INK4b, p16INK4a, p14ARF) and the retinoblastoma (RB) protein.

Purpose of the Study:

  • To investigate the methylation status of cell cycle regulatory genes in adult T-cell leukemia/lymphoma (ATL).
  • To determine the role of gene hypermethylation in ATL pathogenesis.

Main Methods:

  • Methylation-specific polymerase chain reaction (MSP) was employed.
  • Analysis was conducted on tumor cells from 35 adult T-cell leukemia/lymphoma (ATL) patients.

Main Results:

  • At least one cell cycle regulatory gene was methylated in 26% (9 of 35) of ATL cases.
  • The frequency of p15INK4b methylation was 20% (7 of 35).
  • Methylation of p14ARF and p16INK4a occurred in 6% (2 of 35) and 3% (1 of 35) of cases, respectively. RB gene methylation was not detected.

Conclusions:

  • Inactivation of cell cycle regulatory genes via hypermethylation is a significant factor in ATL development.
  • These findings highlight potential therapeutic targets in ATL treatment.